ARTICLE | Company News

Zentaris GmbH, German Research Centre for Biotechnology mgH deal

July 12, 2004 7:00 AM UTC

Zentaris exercised an option to license from the center exclusive worldwide rights to a class of naturally occurring compounds called disorazoles plus the strain of bacteria used to produce them. Whil...